Monday, April 9, 2012

GEN: 'Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors'

Quoting from the April 5th GEN (via Biowire):

"The Colorado BioScience Association (CBSA) appointed four new board members at its 2012 Annual All-Member Meeting held at the Westin Westminster, Westminster, CO, yesterday. The announcement is made jointly by Steve Orndorff, Ph.D., Chairperson of the Board of Directors and Holli Riebel, CBSA President & CEO of CBSA.

Newly appointed CBSA board members include:

James Chomas, Ph.D., Founder & CEO, Surefire Medical - Westminster -www.surefiremedical.com

Scott Deeter, President & CEO, Ventria Bioscience - Fort Collins - www.ventria.com

Brent Fassett, Partner, Cooley LLP - Broomfield - www.cooley.com

Kerry Ingalls
,Vice President of Colorado Operations, Amgen - Boulder/Longmont - www.amgen.com

Riebel says: 'CBSA’s board is a prestigious group of industry leaders comprised of representatives of biotechnology, medical device, diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical services and products to bioscience companies. Board members commit to a three-year term to support CBSA’s mission to support the regional bioscience community through advocacy, resources and advancement of opportunities for collaboration. CBSA board members work in partnership with staff to support the drive and determination of over 600 Colorado bioscience companies that work to improve lives locally and around the world.'"

Link to GEN

NCBR: 'Colorado BioScience Association appoints Deeter to board'

Quoting from the April 5th Northern Colorado Business Report:

"The Colorado BioScience Association has named four new board members, including Scott Deeter, president and CEO of Ventria Bioscience in Fort Collins.

James Chomas, founder and CEO of Surefire Medical in Westminster, Brent Fassett, partner at Cooley LLP in Broomfield, and Kerry Ingalls, vice president of Amgen's Colorado operations, also were appointed. Board members commit to a three-year term to back the regional bioscience community."

Link to the NCBR

CRJ: 'Colorado bioscience cluster alive and well'

Quoting from the April 4th article in the Colorado Real Estate Journal:

"The biosciences industry is alive and well in the Denver metro area, and that bodes well for future demand for manufacturing and lab/research-and-development space.

'Bioscience is one of the few industry sectors that have grown during the bad economy and actually exceeded the national average,' said Holli Riebel, president and CEO of the Colorado BioScience Association.'"

Link to the article

'Made in Colorado: Pharmaceuticals and Medical Technology'

More than a dozen of the Colorado BioScience Association member companies are featured in the current ColoradoBiz Magazine 'Made In Colorado' feature by Debra Melani.

Link to read

Friday, April 6, 2012

The Tails of the Painted Cats Video Art Gallery is OPEN!

Cat Care Society Tails of the Painted Cats - 2012.

Check out our Video Art Gallery:

http://youtu.be/F_MNKEMJGKE

One-of-a-kind "painted cats" by well-known Denver artists will once again raise funds for the Cat Care Society's shelter cats and community outreach programs. The cats will be unveiled at the Lakewood Arts Council Co-op Gallery in May (reception May 3) and will reside there through the month. In June the cats will be at various galleries in the Santa Fe Arts District for the First Friday Art Walk June 1. On June 29, the cats arrive at the Aar River Gallery in Westminster for the CCS wine tasting (featuring our CCS Cat Care Vineyards wines!). Finally, the cats head to various businesses and galleries in the Tennyson Street Cultural District, before heading to Lakewood Country Club for the July 28th Gala Dinner Auction emceed by CBS4's Ed Greene.

Visit the Tails of the Painted Cats Facebook page: http://www.facebook.com/TailsofthePaintedCats

Thursday, April 5, 2012

Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors

The Colorado BioScience Association (CBSA) appointed four new board members at its 2012 Annual All-Member Meeting held at the Westin Westminster, Westminster, CO, yesterday. The announcement is made jointly by Steve Orndorff, Ph.D., Chairperson of the Board of Directors and Holli Riebel, CBSA President & CEO of CBSA.

Newly appointed CBSA board members include:

* James Chomas, Ph.D., Founder & CEO, Surefire Medical - Westminster - www.surefiremedical.com
* Scott Deeter, President & CEO, Ventria Bioscience - Fort Collins - www.ventria.com
* Brent Fassett, Partner, Cooley LLP - Broomfield - www.cooley.com
* Kerry Ingalls, Vice President of Colorado Operations, Amgen - Boulder/Longmont - www.amgen.com

Riebel says: "CBSA’s board is a prestigious group of industry leaders comprised of representatives of biotechnology, medical device, diagnostic, pharmaceutical, health care providers, research institutions and those businesses that provide critical services and products to bioscience companies. Board members commit to a three-year term to support CBSA’s mission to support the regional bioscience community through advocacy, resources and advancement of opportunities for collaboration. CBSA board members work in partnership with staff to support the drive and determination of over 600 Colorado bioscience companies that work to improve lives locally and around the world."

“On behalf of the Board of Directors, I would like to thank the retiring eleven directors for their service and welcome the four new appointees,” Orndorff stated. Special recognition was given to Norwood Robb for serving on the board for ten years. The Executive Officers , in addition to Orndorff, is now instated as Derek Cole, Board Vice Chair, Vice President, Investor Relations & Corporate Communications, ARCA Biopharma; Jim Wilson, Board Treasurer, Senior Audit Manager, Ernst & Young; and John Dunning, Board Secretary, President & CEO, Clarimedix Inc.

Link to the Business Wire Newswire

Sunday, April 1, 2012

BioBeers Denver: April 25th at the new Cedar Creek Pub

Mark your calendars: April 25, 6:30 p.m.

The new home for BioBeers Denver is only a chip shot from the Fitzsimons-based Bioscience Park Center building; the new Cedar Creek Pub promises to provide an ideal backdrop for BioBeers networking, knowledge exchange and fun. Note: the 2100 North Ursula St. address is off of Montview Blvd. in the 21 Fitzsimons round-about.

No admission - "Buy Your Own Beer" - for casual networking with your Denver med device, biopharma and diagnostics colleagues.

Link to RSVP at the BioBeers Meetup Site